Skip to main content
 

Alerts and Recalls

Top
  • FDA Statement: Impact of IV Fluid Shortages Following Hurricane Destruction

    Monday, November 20, 2017
    Update on the efforts by the FDA to address IV fluid shortages exacerbated by Hurricane Maria and advice for hospitals in managing the shortage

    Read More
  • Baxter Issues A Voluntary Nationwide Recall For One Lot of Nexterone Injection Due To Presence Of Particulate Matter

    Thursday, November 16, 2017
    Baxter International Inc. announced today it is voluntarily recalling one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection – distributed between 8/23/2017 and 10/2/2017 in the United States to wholesalers/distributors and healthcare facilities – due to the potential presence of...

    Read More
  • Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

    Thursday, November 16, 2017
    FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of heart-related death with febuxostat (Uloric) compared to another gout medicine called allopurinol. FDA required the Uloric drug manufacturer, Takeda Pharmaceuticals, to conduct this safety...

    Read More
  • Midazolam Injection, USP, 2 mg/2 mL by Fresenius Kabi: Recall

    Monday, November 6, 2017
    Fresenius Kabi USA is voluntarily recalling Lot of Midazolam Injection, USP, 2 mg/2 mL packaged in a 2 mL prefilled single-use glass syringe to the hospital/user level. The product mislabeled as Midazolam Injection, USP, 2 mg/2 mL contains syringes containing and labeled as Ondansetron Injection,...

    Read More
  • Advice for Providers Treating Patients in or Recently Returned from Hurricane-Affected Areas, Including Puerto Rico and US Virgin Islands

    Wednesday, October 25, 2017
    The purpose of this HAN advisory is to remind clinicians assessing patients currently in or recently returned from hurricane-affected areas to be vigilant in looking for certain infectious diseases, including leptospirosis, dengue, hepatitis A, typhoid fever, vibriosis, and influenza. Additionally,...

    Read More
  • Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

    Monday, October 23, 2017
    ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. The is a potential for the products to contain microbial contamination. See the recall notice for a full list of products.

    Read More
  • St. Jude Medical Recalls Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy Defibrillators (CRT-D)

    Friday, October 20, 2017
    St. Jude Medical Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are devices that provide pacing for slow heart rhythms, and electrical shock or pacing to stop dangerously fast heart rhythms. ICDs and CRT-Ds are both implanted under the...

    Read More
  • Intralipid 20 Percent IV Fat Emulsion by Baxter: Recall

    Saturday, October 7, 2017
    Baxter International Inc. announced today it is voluntarily recalling one shipment from a single lot of INTRALIPID 20% IV Fat Emulsion, 100 mL, distributed between 8/11/17 and 8/31/17 to hospitals and healthcare providers in the United States, to the user level. The product has been exposed to...

    Read More
  • Hurricanes Irma and Maria in the Caribbean Alert - Level 2, Practice Enhanced Precautions

    Tuesday, September 26, 2017
    Beginning on September 6, 2017, Hurricane Irma crossed the Caribbean, followed on September 16 by Hurricane Maria. The extent of destruction across these countries and territories varies, with many areas flooded and inaccessible. Significant damage from the hurricane has caused problems with water...

    Read More
  • Class 2 Device Recall Baxter Amia Automated Peritoneal Dialysis Set with Cassette

    Friday, September 22, 2017
    The firm (Baxter) initiated the recall by letter on 09/05/2017. The patients and clinics were directed to locate and remove all affected product and to contact Baxter Healthcare Center for Service to arrange for return and credit. The Baxter Healthcare Center for Service can be reached at...

    Read More